Our team advised Stanley Capital Partners on all Luxembourg legal aspects regarding the acquisition of a majority stake in the French pharmaceutical group Laboratoire X.O.

The acquisition itself was financed with a combination of committed funding facilities and debt funding. Laboratoire X.O. was founded in 2015 and specialises in the production of medicine, medical devices and cosmetics.